Coronavirus statements

Update from the Vice-Chancellor

25 September 2020

Update from the Vice-Chancellor about the public health campaign, living, working and studying in Cambridge, testing, returning to the workplace, and the 1st Oc...

What's happening

Research
Coronavirus

Cambridge-developed SARS-CoV-2 vaccine receives £1.9million from UK government for clinical trial

A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government.

Read more
Research
Man taking COVID-19 test

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.

Read more

Research
Sheffield's Women of Steel - COVID-19: We can beat this

Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus

The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19.

Read more

Research
Man wearing a face mask

Ageing heart cells offer clues to susceptibility of older people to severe COVID-19

Genes that play an important role in allowing SARS-CoV-2 to invade heart cells become more active with age, according to research published today in the Journal of Molecular and Cellular Cardiology

Read more